Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

EGFR-IN-172

Catalog No. T213103 Copy Product Info
🥰Excellent
EGFR-IN-172 is an EGFR inhibitor that effectively suppresses the proliferation of non-small cell lung cancer (NSCLC) cells with L858R, T790M, and C797S drug-resistant mutations. It inhibits the phosphorylation of EGFR, leading to cell cycle arrest and apoptosis. EGFR-IN-172 is suitable for NSCLC research.

EGFR-IN-172

Copy Product Info
🥰Excellent
Catalog No. T213103

EGFR-IN-172 is an EGFR inhibitor that effectively suppresses the proliferation of non-small cell lung cancer (NSCLC) cells with L858R, T790M, and C797S drug-resistant mutations. It inhibits the phosphorylation of EGFR, leading to cell cycle arrest and apoptosis. EGFR-IN-172 is suitable for NSCLC research.

EGFR-IN-172
Cas No. 878416-74-1
Pack SizePriceUSA StockGlobal StockQuantity
10 mgInquiry10-14 weeks10-14 weeks
50 mgInquiry10-14 weeks10-14 weeks
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
EGFR-IN-172 is an EGFR inhibitor that effectively suppresses the proliferation of non-small cell lung cancer (NSCLC) cells with L858R, T790M, and C797S drug-resistant mutations. It inhibits the phosphorylation of EGFR, leading to cell cycle arrest and apoptosis. EGFR-IN-172 is suitable for NSCLC research.
In vitro
EGFR-IN-172 (Compound 2b) exhibits significant antiproliferative activity, with IC50 values of 5.31 μM for A549 cells (EGFR WT), 0.55 μM for PC-9 cells (EGFR T790M), 0.40 μM for H1975 cells (EGFR L858R/T790M), and 2.36 μM for Ba/F3-EGFR L858R/T790M/C797S cells. At concentrations ranging from 0.1 to 10 μM, it inhibits EGFR (pEGFR) in H1975 and Ba/F3 triple mutant cells in a concentration-dependent manner. EGFR-IN-172 (0.25-1 μM, 48 h) causes H1975 cells to arrest in the G0/G1 phase, although it does not significantly affect the cell cycle of Ba/F3 triple mutant cells. Additionally, at the same concentration range and duration, it induces apoptosis in both H1975 and Ba/F3 triple mutant cells in a concentration-dependent fashion.
Chemical Properties
Molecular Weight359.4
FormulaC22H18FN3O
Cas No.878416-74-1
SmilesFC1=CC=CC(=C1)C(NC2=NC=CC(=C2)C)C=3C=CC4=CC=CN=C4C3O
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy EGFR-IN-172 | purchase EGFR-IN-172 | EGFR-IN-172 cost | order EGFR-IN-172 | EGFR-IN-172 in vitro | EGFR-IN-172 formula | EGFR-IN-172 molecular weight